STAGE PROGRESSION IN TA PAPILLARY UROTHELIAL TUMORS: RELATIONSHIP TO GRADE, IMMUNOHISTOCHEMICAL EXPRESSION OF TUMOR MARKERS, MITOTIC FREQUENCY AND DNA PLOIDY
The Journal of Urology, ISSN: 0022-5347, Vol: 165, Issue: 4, Page: 1124-1130
2001
- 181Citations
- 42Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
We studied 363 patients with stage Ta bladder tumors during long-term followup who were classified according to the 1998 WHO and International Society of Urological Pathology consensus classifications. We determine whether various immunohistochemical and molecular markers could predict tumor progression.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0022534705664439; http://dx.doi.org/10.1016/s0022-5347(05)66443-9; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0035091393&origin=inward; http://linkinghub.elsevier.com/retrieve/pii/S0022534705664439; http://api.elsevier.com/content/article/PII:S0022534705664439?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S0022534705664439?httpAccept=text/plain; http://www.jurology.com/doi/10.1016/S0022-5347%2805%2966443-9; http://dx.doi.org/10.1016/s0022-5347%2805%2966443-9; https://dx.doi.org/10.1016/s0022-5347%2805%2966443-9; https://www.auajournals.org/doi/10.1016/S0022-5347%2805%2966443-9
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know